Randomized Phase II Trial of Either Fluorouracil, Parenteral Hydroxyurea, Interferon-??t-2a, and Filgrastim or Doxorubicin/Docetaxel in Patients with Advanced Gastric Cancer with Quality-of-Life Assessment
2002 ◽
Vol 8
(3)
◽
pp. 282-286
◽
2016 ◽
Vol 22
(8)
◽
pp. 581-588
◽
2013 ◽
Vol 190
(3)
◽
pp. 857-862
◽
2015 ◽
Vol 33
(1)
◽
pp. 46-47